BKNG vs TCRX · P/E 36, rev $7.35B vs rev $2.0M
Booking Holdings Inc (BKNG) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Booking Holdings Inc (BKNG) is a travel services company listed on US. It is led by Glenn D. Fogel.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported BKNG revenue for 2026-06-30 was $7.35B. Revenue was up 32.9% from 2026-03-31 to 2026-06-30. BKNG currently screens at market cap $186.03B and trailing P/E 35.6.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
BKNG currently screens at market cap $186.03B and trailing P/E 35.6. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the BKNG and TCRX stock pages for the full models.
Not investment advice.